TLX News: Illuccix® Available on High Activity Gallium Generator Technology to Meet High Demand - 22nd Nov 2022, 11:00pm

[annb0t]

INDIANAPOLIS, Nov. 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces Illuccix® (kit for the preparation of gallium Ga 68 gozetotide injection) with up to 50mCi for radiolabeling is available for use on 100mCi (millicurie) gallium generators, an important development in radioisotope production. (PRNewsfoto/Telix Pharmaceuticals Limited)

High activity generators from Eckert & Ziegler Strahlen- und Medizintechnik AG (EZAG) and IRE ELiT S.A. (t...

>>> Read more: Illuccix® Available on High Activity Gallium Generator Technology to Meet High Demand